One of the universal truths of health care is drugs don't work if people don't take them. But there are new devices in development that may help patients take their medications as required for up to several months.
Jul 04, 2019
0
2
Tuberculosis is a potentially deadly though curable disease. Each year about 10 million people develop active cases, and 1.6 million people die. In addition, about 1.7 billion people around the world are infected with TB ...
May 14, 2019
0
74
(HealthDay)—The U.S. Food and Drug Administration has announced the approval of Dovato (dolutegravir and lamivudine), the first approved two-drug, fixed-dose, complete regimen for adults with HIV-1 who have not been previously ...
Apr 09, 2019
0
0
(HealthDay)—High blood pressure is one of the biggest risk factors for heart disease and stroke, yet has no symptoms of its own. That's why having your blood pressure checked regularly is a must, as is controlling it if ...
Jun 20, 2018
0
2
Research carried out by St George's, University of London into tuberculosis treatments has clearly shown the 'persistent bacteria' that make treating the disease so difficult for the first time, using a new combination therapy.
Jun 01, 2018
0
1
An international team of researchers has shown that two different compounds-one, an older malaria drug, the other a common laboratory dye with known antimalarial properties-can safely and effectively be added to treatment ...
Feb 06, 2018
0
13
A new review discusses important consideration when caring for children who have received liver transplants.
Jan 17, 2017
0
0
(HealthDay)—The association between medication regimen complexity and either treatment nonadherence or hospitalization in elderly patients remains unclear, according to a review published online Dec. 19 in the Journal of ...
Dec 23, 2016
0
1
Researchers have created a new drug delivery system that could improve the effectiveness of an emerging concept in cancer treatment - to dramatically slow and control tumors on a long-term, sustained basis, not necessarily ...
Aug 26, 2016
2
210
Osteosarcoma patients with tumors that haven't responded well to the standard chemotherapy regimen have unimproved outcomes and more side effects when given two additional drugs, a large international trial has found.
Aug 26, 2016
0
0
